AQR Capital Management - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 128 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$312,000
-34.5%
63,059
-18.7%
0.00%
-50.0%
Q3 2013$476,000
-60.9%
77,567
-62.8%
0.00%
-50.0%
Q2 2013$1,218,000
-32.8%
208,267
-39.5%
0.00%
-50.0%
Q4 2012$1,813,000343,9670.01%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 5,427,559$2,334,0001.60%
Scale Management, LLC 1,312,575$564,0001.34%
Foresite Capital Management III, LLC 2,542,575$1,093,0000.75%
BVF INC/IL 5,252,100$2,258,0000.48%
TIVERTON ASSET MANAGEMENT LLC 45,313$4,261,0000.18%
Baupost Group 22,268,399$9,575,0000.13%
Rhenman & Partners Asset Management AB 1,200,000$516,0000.09%
NEA Management Company, LLC 370,900$1,595,0000.08%
SAMLYN CAPITAL, LLC 6,160,417$2,649,0000.06%
Palo Alto Investors LP 1,673,024$719,0000.05%
View complete list of OREXIGEN THERAPEUTICS INC shareholders